Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission.

Autor: Ninomiya, Toshifumi^1,2 (AUTHOR), Otsubo, Kohei¹ (AUTHOR) kohei.otsubo@gmail.com, Hoshino, Teppei³ (AUTHOR), Shimokawa, Mototsugu⁴ (AUTHOR), Nakazawa, Megumi² (AUTHOR), Sato, Yoriko² (AUTHOR), Mikumo, Hironori² (AUTHOR), Kawakami, Satoru^2,5 (AUTHOR), Mizusaki, Shun^1,2 (AUTHOR), Mori, Yusuke³ (AUTHOR), Arimura, Hidenobu¹ (AUTHOR), Tsuchiya-Kawano, Yuko¹ (AUTHOR), Inoue, Koji¹ (AUTHOR), Uchida, Yujiro² (AUTHOR), Nakanishi, Yoichi⁶ (AUTHOR)

Publikováno v: BMC Infectious Diseases. 8/21/2021, Vol. 21 Issue 1, p1-6. 6p.

Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR‐mutant non‐small cell lung cancer.

Autor: Mizusaki, Shun, Otsubo, Kohei, Ninomiya, Toshifumi, Arimura, Hidenobu, Tsuchiya‐Kawano, Yuko, Inoue, Koji

Publikováno v: Thoracic Cancer; Jan2021, Vol. 12 Issue 1, p114-116, 3p